insights_auto
Why is BOT down 9.09%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
arrow_downward
-9.09%(-0.0010) 1D
Nov 6, 10:23:12 AM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
9.20M
Volume
529.98K
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
9.20M
Volume
529.98K
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
BigGo Finance
·
19 minutes ago
AI Stocks Plunge, Nasdaq Enters Correction as Futures Slide Ahead of Payrolls
Nacionale
·
35 minutes ago
What is the VIX? Wall Street's 'fear gauge' jumped about 70% as tech stocks sank
Seeking Alpha
·
8 minutes ago
I Was Tired Of Winning (SP500)
Traders Union
·
2 hours ago
Michael Saylor: S&P 500 and Nasdaq see sharp declines, Bitcoin drops about 5 percent
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com